Guidance

DTaP/IPV (Infanrix®-IPV or Repevax®) : PGD template

PGD template to support the national diphtheria, tetanus, pertussis and poliomyelitis vaccination programme.

Documents

Diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (DTaP/IPV or dTaP/IPV): patient group direction (PGD) template

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template is to support the administration of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (DTaP/IPV or dTaP/IPV), from 3 years 4 months to under 10 years of age, in accordance with national recommendations and the routine childhood immunisation programme.

It is valid from 1 December 2017 to 30 November 2019.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 7 January 2016
Last updated 19 October 2017 + show all updates
  1. Reviewed: updated to add management of cases and contacts.
  2. First published.